David A. Sinclair A.O., Ph.D.

David A. Sinclair A.O., Ph.D. has extensive work experience in the field of aging and biological research. David A. started their career at Harvard University in 1999 as a Professor and continues to work there. In 2005, they became the Co-Director of the Paul F. Glenn Center for Biology of Aging Research, which focuses on extending the healthy years of life through research. In 2008, they took on the role of Co-Editor in Chief for the journal Aging.

In addition to their academic roles, Sinclair has been involved in various organizations and companies. In 2017, they became a Board Member, Investor, and Advisor for Life Biosciences, a company specializing in pharmaceuticals based on the science of aging. David A. co-founded the Academy for Health & Lifespan Research in 2019 and Fully Aligned Co, LLC and Tally Health in 2022, serving as a Co-Founder for all three. David A. also co-founded Animal Bioscience in 2018 and EdenRoc Sciences, LLC in 2012. Additionally, in 2020, they co-founded Immetas Therapeutics and serves as a board member.

Through their diverse roles and involvement in various organizations, Sinclair has made significant contributions to the field of aging research and is a respected figure in the scientific community.

David A. Sinclair A.O., Ph.D. obtained their B.S. and Ph.D. degrees from UNSW from 1987 to 1995, focusing on Genetics, Molecular Biology, Biochemistry, and Marine Biology. David A. then pursued further education at the Massachusetts Institute of Technology from 1995 to 1999, engaging in Postdoctoral Training in the field of Genetics.